Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

182 results
Display

Clinical effectiveness of live attenuated herpes zoster vaccine in kidney transplant recipients immunized prior to kidney transplantation: a retrospective single-center cohort study

Kim SH, Huh K, Lee KW, Park JB, Huh WS, Ko JH, Peck KR

Background: Kidney transplant recipients have an increased risk of herpes zoster (HZ) and its complications. Although live attenuated or recombinant subunit zoster vaccine has been recommended for candidates for kidney...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Disseminated Pneumococcal Infection with Meningitis and Septic Arthritis Caused by Extensively Drug-resistant Streptococcus pneumoniae

Shi HJ, Baek JY, Chung DR, Kim K, Peck KR, Kang CI

The emergence and spread of antimicrobial resistance threatens the successful treatment of invasive pneumococcal disease (IPD). We report a case of disseminated pneumococcal infection with meningitis, spondylitis, and septic arthritis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea

Shi HJ, Nham E, Kim B, Joo EJ, Cheong HS, Hong SH, Hyun M, Kim Ha, Jang S, Rhee JY, Kim J, Kim S, Cho HK, Wi YM, Cheon S, Kim YS, Lim S, Seok H, Jung SI, Eom JS, Peck KR

Background: Numerous patients around the globe are dying from coronavirus disease 2019 (COVID-19). While age is a known risk factor, risk analysis in the young generation is lacking. The present...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study

Kim SH, Hong JY, Bae S, Lee H, Wi YM, Ko JH, Kim B, Joo EJ, Seok H, Shi HJ, Yoo JR, Hyun M, Kim Ha, Jang S, Mun SJ, Kim J, Kim MC, Jung DS, Kim SH, Peck KR

Background: Coronavirus disease 2019 (COVID-19) is often accompanied by secondary infections, such as invasive aspergillosis. In this study, risk factors for developing COVID-19-associated pulmonary aspergillosis (CAPA) and their clinical outcomes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19

Hong JY, Ko JH, Yang J, Ha S, Nham E, Huh K, Cho SY, Kang CI, Chung DR, Baek JY, Sohn YM, Park HJ, Lee B, Huh HJ, Kang ES, Suh GY, Chung CR, Peck KR

Purpose: Real-world experience with tocilizumab in combination with dexamethasone in patients with severe coronavirus disease (COVID-19) needs to be investigated. Materials and Methods: A retrospective cohort study was conducted to evaluate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward

Wi YM, Kim SH, Peck KR

Background: A rapid decline in immunity and low neutralizing activity against the delta variant in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinees has been observed. This study describes an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19

Shin HS, Park H, Kwon JS, Namgoong H, Kim SJ, Kim JM, Peck KR, Lee K, Lee Jk, Lee J, Han HC, Hong S, Park BJ, Lim TH, Hwang ES, Woo JH, NC1C

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine

Huh K, Na Y, Kim YE, Radnaabaatar M, Peck KR, Jung J

We used the nationwide claims database to calculate the incidence of thrombotic events and predict their overall 2-week incidence. From 2006 to 2020, the incidence of deep vein thrombosis (DVT),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARSCoV-2 Monoclonal Antibody Treatment of Patients with COVID-19

Kim SB, Kim J, Huh K, Choi WS, Kim YJ, Joo EJ, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Yu SY, Peck KR, Choi M, Yeom JS, Korean Society of Infectious Diseases (KSID)

Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea

Choi MJ, Choi WS, Seong H, Choi JY, Kim JH, Kim YJ, Cho EY, Kim DH, Park H, Lee H, Kim NJ, Song JY, Cheong HJ, Kim SI, Peck KR

Background: This study presents a framework for determining the allocation and distribution of the limited amount of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: After analyzing the pandemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience

Kim SH, Wi YM, Yun SY, Ryu JS, Shin JM, Lee EH, Seo KH, Lee SH, Peck KR

Coronavirus disease 2019 vaccinations for healthcare workers (HCWs) have begun in South Korea. To investigate adverse events (AEs) of the first dose of each vaccine, any symptom was collected daily...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19

Kim SB, Ryoo S, Huh K, Joo EJ, Kim YJ, Choi WS, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Park Da, Yu SY, Lee HJ, Kim J, Jin Y, Park J, Peck KR, Choi M, Yeom JS, D

Despite the global effort to mitigate the spread, coronavirus disease 2019 (COVID-19) has become a pandemic that took more than 2 million lives. There are numerous ongoing clinical studies aiming...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study

Joo EJ, Ko JH, Kim SE, Kang SJ, Baek JH, Heo EY, Shi HJ, Eom JS, Choe PG, Bae S, Ra SH, Kim DY, Kim BN, Kang YM, Kim JY, Chung JW, Chang HH, Bae S, Cheon S, Park Y, Choi H, Lee E, Lee By, Park JW, Sohn Y, Heo JY, Kim SH, Peck KR

Background: Remdesivir is widely used for the treatment of coronavirus disease 2019 (COVID-19), but controversies regarding its efficacy still remain. Methods: A retrospective cohort study was conducted to evaluate the effect...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Collaborative Response to COVID-19 Pandemic, and Development of Treatment Guidelines

Peck KR

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018

Ko JH, Woo Ht, Oh HS, Moon SM, Choi JY, Lim JU, Kim D, Byun J, Kwon SH, Kang D, Heo JY, Peck KR

Background/Aims Human adenovirus type 55 (HAdV-55), an emerging epidemic strain, has caused several large outbreaks in the Korean military since 2014, and HAdV-associated acute respiratory illness (HAdV-ARI) has been continuously reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Debate on Public Health Responses to COVID-19: Focused Protection versus Sustained Suppression

Song JY, Peck KR, The Korean Society of Infectious Diseases

With the coronavirus disease 2019 (COVID-19) pandemic persisting for a long time, there have been debates about the public health response strategies. We conducted a survey of adult infectious disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Systematic Narrative Review of Comprehensive Preparedness Strategies of Healthcare Resources for a Large Resurgence of COVID-19 Nationally, with Local or Regional Epidemics: Present Era and Beyond

Yoon YK, Lee J, Kim SI, Peck KR

Coronavirus disease 2019 (COVID-19) has penetrated our daily lives, leading us to a new normal era. The unexpected impact of COVID-19 has posed a unique challenge for the health care...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
What should we prepare for the next coronavirus disease 2019 outbreak? A survey on the opinions of infectious diseases specialists in South Korea

Kim B, Park SY, Jung DS, Jung SI, Oh WS, Kim SW, Peck KR, Chang HH, The Korean Society of Infectious Diseases

Background/Aims: This study aimed to collect information on the opinions of Korean infectious disease (ID) experts on coronavirus disease 2019 (COVID-19) and related issues in preparation for a future outbreak. Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The First Case of an HIV Patient Diagnosed with COVID-19 in Korea

Kim JY, Kim JM, Peck KR

Although some comorbidities, such as diabetes mellitus, lung disease, and chronic kidney disease, are known as risk factors for poor clinical outcome in patients with coronavirus disease 2019 (COVID-19), it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for Surgery of Confirmed or Suspected COVID-19 Patients

Lee JS, Yum HK, Si HJ, Han SH, Park SY, Peck KR, Eom JS, Korean Society of Infectious Diseases (KSID) and Korea Medical Association Task Force Expert Committee

Coronavirus disease 2019 (COVID-19) has spread widely across the world since January 2020. There are many challenges when caring for patients with COVID-19, one of which is infection prevention and control....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr